Company Profile

Home
Markets
Company Profile

Tata Motors
613.20 606.20(%)
Hindalco Inds.
607.00 558.00(%)
Hind.Aeronautics
4,205.05 3,045.95(%)
Reliance Industr
1,192.85 1,156.00(%)
Mazagon Dock
2,542.50 995.38(%)
Vedanta
403.50 297.70(%)
Interglobe Aviat
5,150.65 5,187.00(%)
Infosys
1,451.50 1,359.10(%)
Bajaj Finance
8,795.75 9,258.95(%)
HDFC Bank
1,842.20 1,880.00(%)
TCS
3,307.55 3,396.10(%)
Nippon ETF Liq.
999.99 996.00(%)
Suzlon Energy
55.00 37.95(%)
Vodafone Idea
7.85 6.60(%)
ICICI Bank
1,336.40 1,372.50(%)
Jio Financial
221.70 198.60(%)
Angel One
2,306.00 1,942.00(%)
Larsen & Toubro
3,251.30 3,141.30(%)
O N G C
225.70 215.20(%)
IndusInd Bank
675.40 605.40(%)

Overview
Key Ratios
Financials
Shareholding
Company Info
Peer Comparison

Supriya Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

Indian Private
BSE Code : 75656.0
ISIN : INE07RO01027

795.10 9 (1.11%)

As on 04 Apr 2025 (EOD)

Today’s Low
775.00
Today’s High
842.00

Open
780.00
Perv Close
786.40
52W Low
330.00
52W High
842.00

Key Indicators

P/E(TTM)

36.64
Mar.Cap (₹Cr.)

6,399.19
Div & Yield %

0.10
Book Value(₹)

112.56
Debt-Equity Ratio

1.11
AGM Date

03-Apr-2025
EPS

21.68
P/E Ratio

36.64

Financials Ratios

Debt-Equity Ratio

-
Mar.Cap (₹Cr.)

6,399.19

RONW (%)

-
ROCE (%)

-

Score Board

Equity (₹ in Cr.)

16.10
BV (₹)

112.60
Sales( ₹ in Cr.)

570.37
NP (in Cr.)

119.11
NP Var(%)

32.0
Div%

40.0
CPS (₹)

16.80
EPS (₹)

14.80
Traded Value (₹ in Lakhs)

6,392.75

52 Week High

842.00
52 Week Low

330.00
Price BSE

794.0
Price NSE

795.00
Market Capital( in Cr.)

6,392.75
P/C Ratio

47.40
P/E Ratio

53.60
Price Vs.BV

14.80

10-Mar-2025( 03:37)

Corporate News - Board... - The Board of Supriya Lifescien...
06-Mar-2025( 09:34)

Corporate News - Supri... - Supriya Lifesciences will hold...
24-Jan-2025( 05:00)

Results - Announcements - Supri... - Net profit of Supriya Lifescie...
17-Jan-2025( 11:05)

Corporate News - Supri... - Supriya Lifesciences will hold...

Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)

Particulars(INCOME)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Sales Turnover	646.96	516.47	588.52	430.97	359.56	321.28
Excise Duty	634.03	506.55	577.84	425.12	359.56	321.28
Net Sales	646.96	516.47	588.52	430.97	359.56	321.28
Other Income	10.64	9.49	7.58	5.01	11.07	8.02
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	581.01	470.43	537.63	396.22	322.71	285.86
EXPENDITURE :
Raw Materials	634.03	506.55	577.84	425.12	359.56	321.28
Power & Fuel Cost	634.03	506.55	577.84	425.12	359.56	321.28
Employee Cost	67.64	55.58	49.08	32.76	25.59	18.97
Other Manufacturing Expenses	12.84	8.51	4.84	2.92	2.98	2.15
Selling & Administrative Expenses	39.73	37.41	33.92	31.89	21.95	18.46
Miscellaneous Expenses	12.84	8.51	4.84	2.92	2.98	2.15
Less : Pre-operative Expenses Capitalised :
Total Expenditure	415.32	346.94	330.38	228.91	226.52	228.76
Operating Profit	55.45	49.74	32.42	22.38	24.26	26.64
Interest	2.11	3.08	4.20	4.08	6.85	10.22
Gross Profit	165.69	123.49	207.25	167.31	96.20	57.10
Depreciation	15.81	11.82	10.12	6.76	6.41	5.44
Profit Before Tax	165.69	123.49	207.25	167.31	96.20	57.10
Tax	37.10	30.68	52.19	43.02	25.07	17.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	9.48	2.95	3.25	0.69	-2.23	0.68
Reported Net Profit	119.11	89.86	151.81	123.59	73.35	39.42
Extraordinary Items	165.69	123.49	207.25	167.31	96.20	57.10
Adjusted Net Profit	119.11	89.86	151.81	123.59	73.35	39.42
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	0.00	0.00	0.00	0.00	0.00	0.00
Statutory Appropriations	6.44	4.83	4.83	3.95	14.64	0.00
P & L Balance carried down	119.11	89.86	151.81	123.59	73.35	39.42
Dividend	-	-	-	-	-	-
Preference Dividend	-	-	-	-	-	-
Equity Dividend (%)	40.00	30.00	30.00	27.00	100.00	0.00
Dividend Per Share(Rs)	0.80	0.60	0.60	0.54	10.00	0.00
Earnings Per Share-Unit Curr	14.80	11.16	18.86	16.89	10.02	5.39
Book Value	6.44	4.83	4.83	3.95	14.64	0.00
Book Value(Adj)-Unit Curr	6.44	4.83	4.83	3.95	14.64	0.00

Shareholding Pattern

Promoter Group

68.30%
Public Share Holding

31.70%

Category of Shareholder	No of Shares	% Holdings	Demat Shares	Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0
Sub Total	0	0.00	0	0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group)	10	0.00	10	1
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	54,967,815	68.30	54,967,815	5
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0
Sub Total	54,967,825	68.30	54,967,825	6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	0	0.00	0	0
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	5,248,803	6.52	5,248,803	69
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	2,000,399	2.49	2,000,399	2
Mutual Funds / UTI	535,615	0.67	535,615	7
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	1,425,470	1.77	1,425,470	7
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0
Sub total	9,210,287	11.44	9,210,287	85
2] Non Institution
Bodies Corporate	1,299,074	1.61	1,299,074	399
Clearing Members	177	0.00	177	3
Directors of their Relatives	0	0.00	0	0
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	913,615	1.14	913,615	1,965
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	738,151	0.92	738,151	1,246
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	693,245	0.86	693,245	3
Individuals holding nominal share capital up to Rs. 1 lakh	12,405,590	15.41	12,405,590	85,625
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	370	0.00	370	2
Others	0	0.00	0	0
Sub Total	16,304,688	20.26	16,304,688	89,303
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0
Total Shares held by Custodians and against which Depository Receipts have been issued	0	0.00	0	0
Grand Total ( A + B + C )	80,482,800	100.00	80,482,800	89,394

Company Background

Supriya Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

Supriya Lifescience Ltd
BSE Code : 75656.0
ISIN : INE07RO01027

Incorporation Year

2008
Registered Office

207/208 Udyog Bhavan
Sonawala Road Goregaon (East), Mumbai,
Maharashtra-400063
Telephone

91-22-40332727
FAX
Chairman

Satish Waman Wagh
Managing Director

Satish Waman Wagh
Company Secretary

Prachi Sathe
Auditor

Kakaria & Associates LLP
Face Value

2
Listing

NSE
Registrar

MUFG Intime India Pvt Ltd
C-101 247 Park,
L B S Marg,Vikhroli West
Mumbai - Mumbai-400083

Supriya Lifescience Ltd Peer Comparison

Profit & Loss

Financial Ratios

Balance Sheet

Company Name	LTP (₹)	Revenue	Sales	P/E Ratio	ROCE %
Supriya Lifesci.	794.30	581.01	646.96	36.64	22.05
Abbott India	29,940.35	6,097.18	5,848.91	47.68	44.71
Astrazeneca Phar	8,092.00	1,330.33	1,295.53	208.61	33.26
P & G Health Ltd	5,295.80	1,166.89	1,151.26	37.16	39.76
Glaxosmi. Pharma	2,857.90	3,530.73	3,407.25	56.83	44.44
Cipla	1,495.15	17,645.00	16,574.34	25.63	20.10
Amrutanjan Healt	666.30	437.58	421.23	39.06	20.84
Fermenta Biotec.	305.85	315.24	307.09	28.99	4.10
Guj. Themis Bio.	282.25	174.19	169.82	58.44	44.82
Bliss GVS Pharma	126.20	638.96	605.46	28.88	11.19
Ambalal Sarabhai	40.33	11.70	3.81	17.24	1.92

Tata Motors

Hindalco Inds.

Hind.Aeronautics

Reliance Industr

Mazagon Dock

Vedanta

Interglobe Aviat

Infosys

Bajaj Finance

HDFC Bank

TCS

Nippon ETF Liq.

Suzlon Energy

Vodafone Idea

ICICI Bank

Jio Financial

Angel One

Larsen & Toubro

O N G C

IndusInd Bank

Supriya Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

795.10 9 (1.11%)

Key Indicators

Financials Ratios

Score Board

Navigate The Market With Confidence

Financials

Shareholding Pattern

Company Background

Supriya Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

Supriya Lifescience Ltd Peer Comparison